Tag: sustained release excipients market share

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Expansion Rate of the Sustained Release Excipients Market in the 2024-2033 Forecast?

The market for sustained release excipients has seen substantial growth in recent years. The market size is projected to increase from $1.29 billion in 2023 to $1.41 billion in 2024, with a compound annual growth rate (CAGR) of 9.6%. Reasons for the notable growth during the historical period include heightened demand for regulated drug release, a rise in chronic disease occurrence, adherence and ease for patients, breakthroughs in the pharmaceutical industry, and regulatory backing for extended-release formulations.

In the upcoming years, the market size for sustained release excipients is projected to experience robust growth, reaching $1.96 billion by 2028 with a compound annual growth rate (CAGR) of 8.4%. This spike in growth during the prediction period can be linked to factors such as the rising elderly population, the emphasis on individualized medicine, hurdles in patient compliance, the surge in intricate drug formulations, improvements in disease control, and the broadening of global healthcare. Key trends for the predicted period comprise patient-focused drug delivery, partnerships for formula development, regulatory conformity and safety, world-wide growth of drug formulation technologies, and the impact of biopharmaceuticals.

Claim Your Free Sample of the Global Sustained Release Excipients Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=10822&type=smp

What Factors Are Catalyzing the Growth of the sustained release excipients Market?

The surge in chronic and acute conditions is predicted to fuel the expansion of the sustained-release excipients sector in the future. Chronic and acute ailments are two separate classifications used to categorize diseases based on their length and rate of development. Chronic illnesses are long-lasting medical issues that continue for a protracted period, typically more than three months, while acute ailments exhibit an abrupt onset of intense but short-lived symptoms. These ailments arise suddenly and are typically transient, extending from a few hours to a few days or weeks. Both chronic and acute conditions frequently employ sustained-release excipients in their pharmaceutical formulations. These excipients aid in enhancing patient compliance, maintaining steady drug concentrations, minimizing adverse reactions, and enhancing disease management, thereby driving their sales. For example, data from the World Health Organization (WHO), a Swiss-based specialized healthcare entity, demonstrates that as of September 2022, cardiovascular conditions caused the majority of NCD deaths, impacting 17.9 million people yearly, trailed by chronic respiratory conditions (4.1 million), diabetes (2.0 million, including deaths from kidney disease precipitated by diabetes), and cancer (9.3 million). Additionally, a report from the Pan American Health Organization, a US-based international public health body released in October 2022, indicated that around 10.6 million individuals contracted tuberculosis in 2021, marking a 4.5% increase from 2020. Consequently, the escalating incidence of both chronic and acute conditions is propelling the growth of the sustained-release excipients sector.

Which Segments Are Important in the Sustained Release Excipients Market Landscape?

1) By Product: Gelatin, Polymers, Minerals, Sugars, Alcohol, Chitosan

2) By Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration

3) By Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation

What Are the Groundbreaking Trends in the Sustained Release Excipients Market?

The upswing in product innovation is a primary trend observed in the sustained release excipients market. Leading corporations in this sector are prioritizing the development of new, innovative products to cement their market standing. To illustrate, Nutriventia Limited, a pharmaceutical firm based in India, unveiled Prolanza, a sustained-release ashwagandha constituent (Withania somnifera) in September 2022. As a high-tech Ashwagandha root extract, it provides steady support for stress-reduction. Its distinct release mechanism allows Prolanza to deliver its therapeutic benefits over a prolonged time with just one daily dose. The absorption, bioavailability, and elimination half-life of Prolanza surpassed that of the control, indicating its sustained-release traits. Given that ashwagandha is primarily utilized for its ability to adapt and mitigate stress responses, the long-lasting therapeutic effects of Prolanza are bound to have a more substantial positive impact on health. Derived from natural herbs, the effectiveness of Prolanza has been clinically validated.

Order Now for Fast Delivery of Your Sustained Release Excipients Market Report!

https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report

What Are the Key Regions Powering Growth in the Sustained Release Excipients Market?

North America was the largest region in the global sustained release excipients market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Sustained Release Excipients Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the sustained release excipients market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Sustained Release Excipients Market Include

1. Sustained Release Excipients Market Executive Summary

2. Sustained Release Excipients Market Segments

3. Sustained Release Excipients Market Size And Template Market Growth Rate

4. Key Sustained Release Excipients Market Trends

5. Major Sustained Release Excipients Market Drivers

……

25. Key Mergers And Acquisitions In The Sustained Release Excipients Market

26. Top Sustained Release Excipients Companies

27. Sustained Release Excipients Market Opportunities And Strategies

28. Sustained Release Excipients Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

IoT Telecom Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/iot-telecom-services-global-market-report

Data Monetization in Telecom Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/data-monetization-in-telecom-global-market-report

Telecom Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/telecom-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Market Overview and Growth Projection
The sustained release excipients market has witnessed robust growth in recent years, with promising prospects ahead. In 2023, the market size reached $1.29 billion, poised to ascend to $1.41 billion in 2024 at a notable compound annual growth rate (CAGR) of 9.6%. Looking further, by 2028, the market is expected to flourish even more, reaching $1.96 billion, showcasing a CAGR of 8.4%. These projections underscore the market’s vitality and potential for expansion, attributed to various contributing factors.

Factors Driving Market Growth

1. Increased Demand for Controlled Drug Release: The rise in demand for controlled drug release mechanisms has been a significant driver for the sustained release excipients market.
2. Chronic Disease Prevalence: The prevalence of chronic diseases worldwide has fueled the demand for sustained release excipients due to their effectiveness in managing long-term conditions.
3. Patient Compliance and Convenience: Sustained release excipients offer improved patient adherence, maintaining consistent drug levels and reducing side effects, thus enhancing patient compliance.
4. Pharmaceutical Industry Innovations: Continuous innovations in the pharmaceutical sector have led to the development of advanced drug formulations, further driving the demand for sustained release excipients.
5. Regulatory Support for Extended-Release Formulations: Regulatory bodies’ support for extended-release formulations has provided a conducive environment for market growth.

Major Trends and Developments

1. Patient-Centric Drug Delivery: A notable trend in the forecast period is the shift towards patient-centric drug delivery systems, focusing on personalized medicine and improved patient outcomes.
2. Collaborations for Formulation Development: Collaboration among pharmaceutical companies and excipient manufacturers for formulation development is on the rise, fostering innovation and product diversification.
3. Regulatory Compliance and Safety: Stringent regulatory compliance and emphasis on product safety are driving manufacturers to invest in research and development for safer and more effective excipients.
4. Global Expansion of Drug Formulation Technologies: The globalization of drug formulation technologies is expanding the market reach and accessibility of sustained release excipients across diverse regions.
5. Influence of Biopharmaceuticals: The growing influence of biopharmaceuticals is reshaping the sustained release excipients market landscape, with increasing applications and demand for specialized formulations.

Read More On The Sustained Release Excipients Market Report 2024 – https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report

Rising Prevalence Of Chronic And Acute Diseases Fuels Growth In The Sustained-Release Excipients Market
Understanding Disease Dynamics
The sustained release excipients market is poised for substantial growth, primarily driven by the escalating prevalence of chronic and acute diseases globally. Chronic diseases, characterized by long-lasting medical conditions, and acute diseases, with rapid onset and short duration, have been on the rise. Sustained release excipients play a pivotal role in formulating pharmaceutical products for both categories, aiding in improved disease management and patient adherence.

Market Dynamics and Forecast
The World Health Organization reports a staggering number of deaths attributed to cardiovascular diseases, chronic respiratory illnesses, diabetes, and cancer, highlighting the urgent need for effective treatment modalities. Similarly, the prevalence of tuberculosis has seen a notable increase, necessitating advanced therapeutic interventions. As such, the sustained release excipients market is witnessing unprecedented growth, driven by the imperative to address the escalating burden of disease worldwide.

Sustained Release Excipients Market Advances With Product Innovation
Embracing Innovation
Product innovation emerges as a key trend shaping the sustained release excipients market landscape. Major industry players are investing in research and development to introduce novel products that cater to evolving healthcare needs. For instance, Nutriventia Limited’s launch of Prolanza—an advanced sustained-release ashwagandha ingredient—reflects the industry’s commitment to delivering effective and innovative solutions.

Strategic Acquisitions and Expansions
Pfizer Inc.’s acquisition of Arena Pharmaceuticals underscores the strategic initiatives driving market growth. Arena’s expertise in sustained-release drug formulations enhances Pfizer’s capabilities in inflammation and immunology, paving the way for groundbreaking treatment modalities.

Market Segmentation and Regional Outlook
The sustained release excipients market encompasses various product segments, including gelatin, polymers, minerals, sugars, alcohol, and chitosan, catering to diverse formulation requirements. Furthermore, the market is segmented by route of administration and technology, offering a comprehensive array of solutions to meet industry needs. North America leads the global market, with Asia-Pacific expected to witness significant growth in the forecast period, reflecting the region’s expanding healthcare landscape.

In conclusion, the sustained release excipients market presents a dynamic landscape marked by innovation, strategic collaborations, and evolving regulatory dynamics. As the industry continues to address global healthcare challenges, sustained growth and innovation remain paramount, driving the market towards new frontiers of excellence and efficacy.

Request for A Sample Of The Global Sustained Release Excipients Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=10822&type=smp